Beranda › Kondisi Pasca-COVID (Long COVID) › Kentucky
Uji klinis Kondisi Pasca-COVID (Long COVID) di Kentucky
6 studi untuk Kondisi Pasca-COVID (Long COVID) mencari peserta di lokasi di Kentucky.
Kota di Kentucky
Teks studi resmi (Bahasa Inggris)
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- University of Louisville School of Medicine ( Site 3706), Louisville
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06667700Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Louisville
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05624450A Study of COVID-19 Vaccine(s) in Children and Adults
- Kentucky Pediatric /Adult Research, Bardstown
Menerima pesertaFase 3Sukarelawan sehat diterima
Usia 5 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07798648A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- UL International Travel Clinic, Louisville
- University of Louisville Hospital, Louisville
- University of Louisville School of Medicine, Louisville
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06679140REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19
- University of Kentucky, Lexington
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Mei 2026 · NCT05218083Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID
- University of Louisville Outpatient Care Center, Louisville
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Mar 2025 · NCT06883513Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.